📰 Archives & Recherche

🇺🇸 États-Unis • Santé

🔍 Rechercher dans les archives

📊 2,308 articles archivé(s)
Page 91 / 116
Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar ...

Celldex Presents Positive Data Demonstrating Barzolvolimab Retreatment Achieves Similar ...

- Late breaking Poster Presentation at AAAAI -...

Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of ...

Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of ...

SEP-631 Demonstrated Robust, Dose-Dependent Inhibition of Icatibant-Induced Skin Wheal Formation, with Complete Inhibition Observed at Doses as Low as...

Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of ...

Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of ...

SEP-631 Demonstrated Robust, Dose-Dependent Inhibition of Icatibant-Induced Skin Wheal Formation, with Complete Inhibition Observed at Doses as Low as...

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in ...

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in ...

– Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p < 0.0001)in new analysiswith adjustment for concomitant rescue...

Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of ...

Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of ...

SEP-631 Demonstrated Robust, Dose-Dependent Inhibition of Icatibant-Induced Skin Wheal Formation, with Complete Inhibition Observed at Doses as Low as...

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in ...

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in ...

– Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p < 0.0001)in new analysiswith adjustment for concomitant rescue...

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in ...

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in ...

– Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p < 0.0001)in new analysiswith adjustment for concomitant rescue...

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in ...

Upstream Bio Presents Additional Analyses from the Phase 2 VIBRANT Trial of Verekitug in ...

– Primary endpoint of endoscopic nasal polyp score (NPS) showed reduction of -1.95 (p < 0.0001)in new analysiswith adjustment for concomitant rescue...

Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of ...

Septerna Announces Positive Phase 1 Data for SEP-631, an Oral MRGPRX2 NAM for the Treatment of ...

SEP-631 Demonstrated Robust, Dose-Dependent Inhibition of Icatibant-Induced Skin Wheal Formation, with Complete Inhibition Observed at Doses as Low as...

11 family-approved comfort casseroles you’ll make on repeat

11 family-approved comfort casseroles you’ll make on repeat

When you need something warm and dependable, these comfort casseroles step in without the stress. They’re the kind of meals you’ll keep on standby...

Oral Biologic Shows Promise for Food Allergy Treatment

Oral Biologic Shows Promise for Food Allergy Treatment

(MedPage Today) -- PHILADELPHIA -- Oral remibrutinib (Rhapsido) increased peanut tolerance in adults with proven allergy to it, with benefits in as li...

Community Healthcare Trust (NYSE:CHCT) vs. Four Corners Property Trust (NYSE:FCPT) Head-To-Head Comparison

Community Healthcare Trust (NYSE:CHCT) vs. Four Corners Property Trust (NYSE:FCPT) Head-To-Head Comparison

Four Corners Property Trust (NYSE:FCPT – Get Free Report) and Community Healthcare Trust (NYSE:CHCT – Get Free Report) are both finance companies,...

New method could improve US forecasting of West Nile virus

New method could improve US forecasting of West Nile virus

West Nile virus is the most common mosquito-borne illness in the continental United States and can in rare cases lead to a much more serious disease w...

The Latest: Israel hits Tehran as Iran's counterattacks widen after supreme leader is killed

The Latest: Israel hits Tehran as Iran's counterattacks widen after supreme leader is killed

Israel has launched a new wave of strikes on Iran, while Tehran responded by firing drones and missiles at Israel and U.S. military installations. The...

Solving the Psychological Safety Problem in Healthcare

Solving the Psychological Safety Problem in Healthcare

Safety threats impact more than what is physically visible. The emotional toll is crushing the healthcare workforce from the inside out, and until the...

7 Hidden Stroke Risks Women Face In Midlife And The Habits Proven To Lower Them

7 Hidden Stroke Risks Women Face In Midlife And The Habits Proven To Lower Them

(MENAFN - Saving Advice) Many women enter their 40s and 50s expecting hot flashes, mood shifts, or sleep changes - but few realize this stage of life ...

Scientists make startling discovery when examining prostate cancer tissue

Scientists make startling discovery when examining prostate cancer tissue

New study finds microplastics in 90% of prostate cancer tumors, with double the concentration in cancerous tissue compared to healthy tissue from pati...

Millions of Americans to lose SNAP benefits from TODAY in major eligibility shake-up

Millions of Americans to lose SNAP benefits from TODAY in major eligibility shake-up

MILLIONS of Americans are at risk of losing their crucial food benefits from March 1 under a shake-up to eligibility criteria. The Congressional Budge...

FDA Class I Warning: 60,000 Lbs Of Blueberries Recalled For Listeria

FDA Class I Warning: 60,000 Lbs Of Blueberries Recalled For Listeria

(MENAFN - Budget and the Bees) Opening a freezer to grab fruit for a smoothie should be a healthy choice. For many people, however, that simple act cu...

The 'sweet spot' of overconfidence — project a bit to be perceived as competent, but don't be 'too seduced,' a cognitive neuroscientist explains in a Q&A

The 'sweet spot' of overconfidence — project a bit to be perceived as competent, but don't be 'too seduced,' a cognitive neuroscientist explains in a Q&A

Q&A with cognitive neuroscientist Steve Fleming: What the science of self-awareness can tell us about confident decision-making...